|
|
|
|
| LEADER |
02711nam a22004455i 4500 |
| 001 |
978-3-8349-8323-7 |
| 003 |
DE-He213 |
| 005 |
20151204160605.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2009 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783834983237
|9 978-3-8349-8323-7
|
| 024 |
7 |
|
|a 10.1007/978-3-8349-8323-7
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RA410-410.9
|
| 072 |
|
7 |
|a KCQ
|2 bicssc
|
| 072 |
|
7 |
|a BUS069000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 338.473621
|2 23
|
| 100 |
1 |
|
|a Müller-Langer, Frank.
|e author.
|
| 245 |
1 |
0 |
|a Creating R&D Incentives for Medicines for Neglected Diseases
|h [electronic resource] :
|b An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research /
|c by Frank Müller-Langer.
|
| 264 |
|
1 |
|a Wiesbaden :
|b Gabler,
|c 2009.
|
| 300 |
|
|
|a XIX, 297 p. 8 illus.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a The TRIPS Agreement and Access to Patented Medicines -- Economic Analysis of Patents -- Patent Protection in the Developing World: Theory and Evidence -- Legal and Economic Analysis of Parallel Imports -- Solutions for the Problem of Underinvestment in R&D for Medicines for Neglected Infectious and Tropical Diseases -- Conclusion and Ideas for Further Research.
|
| 520 |
|
|
|a Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank Müller-Langer addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of short-term access to affordable medicines in poor countries. The author analyzes additional push and pull mechanisms to stimulate R&D for pharmaceutical products alongside patent protection which may help mitigate the problem of those consumers in poor countries who lack access to affordable medicines. Furthermore, he reasons that a global regime of banning parallel trade from low-income countries to high-income countries is desirable from a developing country’s perspective.
|
| 650 |
|
0 |
|a Management.
|
| 650 |
|
0 |
|a Industrial management.
|
| 650 |
|
0 |
|a Health economics.
|
| 650 |
|
0 |
|a Medical economics.
|
| 650 |
1 |
4 |
|a Economics.
|
| 650 |
2 |
4 |
|a Health Economics.
|
| 650 |
2 |
4 |
|a Innovation/Technology Management.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783834917300
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-8349-8323-7
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBE
|
| 950 |
|
|
|a Business and Economics (Springer-11643)
|
